STAT+: Will Makary’s FDA voucher program survive?
RevMed's cancer drug feels out of reach for some, SCOTUS preserves key generic drug pathway, and more biotech news
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Read full article →Texas AG investigating energy drinks
The limitations of private health insurance, the quiet collapse of America's research ethics watchdog and other Morning Rounds news
Read full article →STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more
Drugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug review program
Read full article →The World Cup vs. bugs, germs and heat: Here's the game plan
Despite a diminished federal presence, public health departments are preparing for common ailments that could afflict fans who gather for the event — and are keeping an eye on the Ebola outbreak, too.
Read full article →Tiny HHS office tasked with protecting research participants’ safety is running on fumes
OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effectively protect volunteers.
Read full article →Opinion: How living and practicing medicine abroad complicated my beliefs about universal health care systems
“I believe deeply in universal health care. But universal care must also mean universal safety and accountability, not merely universal access.”
Read full article →My husband planned our 'just us' trip and it was perfect. Here's why it worked
For a smooth, rewarding and drama-free couples trip, take as much stress out of the equation as you can — and get comfortable with the fact that a fight may arise (and that's OK).
Read full article →HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapy
Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental antibody treatment.
Read full article →STAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher program
The White House has used the program to reward companies that help its political goals.
Read full article →What RevMed’s pancreatic cancer drug meant for one patient
Why did a presentation on Revolution Medicines' pancreatic cancer drug get a standing ovation? Why did biotech stocks perform so badly this week? Find out on "The Readout LOUD."
Read full article →Weakened public health powers raise outbreak risks
Some jurisdictions have weakened their public health authorities in response to criticism of lockdowns, school closures, mask mandates, vaccine requirements and other COVID-era restrictions.
Read full article →